US Patent Issued to Edgewise Therapeutics on Oct. 21 for "Quinolinone amide compounds and uses thereof" (Colorado, Connecticut, California Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,369, issued on Oct. 21, was assigned to Edgewise Therapeutics Inc. (Boulder, Colo.).

"Quinolinone amide compounds and uses thereof" was invented by Natalie Anne Hawryluk (Nederland, Colo.), Stephen Thomas Schlachter (Boulder, Colo.), Kevin Koch (Niwot, Colo.), Michael Joseph Luzzio (Groton, Conn.), Alan James Russell (Boulder, Colo.), Marc Justin Evanchik (Boulder, Colo.), Carlos Luis Del Rio (San Mateo, Calif.) and Kevin Hunt (Boulder, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure generally relates to substituted quinolinone amide compounds or salts of Formula (I), (II-A), (IV), or (III) and pharmaceutical compositions...